Cytoreductive radical prostatectomy (cRP) in the management of patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC).

被引：0
|
作者：
Heidenreich, Axel
Rieger, Constantin
Kastner, Lucas
Seelemeyer, Felix
Pfister, David
机构：
[1] Univ Hosp Cologne, Dept Urol, Cologne, Germany
[2] Univ Clin Cologne, Dept Urol, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
    Kartolo, Adi
    Tannock, Ian F.
    Badillo, Francisco E. Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3573 - +
  • [42] ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IN MEN WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER (MHNPCA)
    Heidenreich, Axel
    Mazzone, Elio
    Gandaglia, Giorgio
    Pfister, David
    Shariat, Shahrokh
    Grubmueller, Bernhard
    Fossati, Nicola
    Montorsi, Francesco
    Karnes, Jeff R.
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2020, 203 : E363 - E363
  • [43] Prostate radiotherapy in newly-diagnosed metastatic hormone-sensitive prostate cancer: A single-institution experience.
    Morgan, Scott Carlyle
    Holmes, Oliver
    Craig, Julia
    Grimes, Scott
    Eapen, Libni
    Malone, Shawn
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Radical vs palliative RT in metastatic hormone-sensitive prostate cancer
    Yan, K. C. K.
    Mo, F.
    Wong, K.
    ANNALS OF ONCOLOGY, 2024, 35
  • [45] Survival in men with newly diagnosed hormone sensitive metastatic prostate cancer
    Stroomberg, H. V.
    Helgstrand, J. T.
    Brasso, K.
    Roder, A.
    EUROPEAN UROLOGY, 2023, 83
  • [46] Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer
    Barbier, Michaela C.
    Tomonaga, Yuki
    Menges, Dominik
    Yebyo, Henock G.
    Haile, Sarah R.
    Puhan, Milo A.
    Schwenkglenks, Matthias
    PLOS ONE, 2022, 17 (11):
  • [47] Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Hindie, Elif
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3873 - 3875
  • [48] Erstlinientherapie beim metastasierten hormonsensitiven Prostatakarzinom (mHSPC)First-line treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
    H. Rexer
    S. Feyerabend
    M. Graefen
    Forum, 2023, 38 (3) : 238 - 239
  • [49] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Kenrick Ng
    Shievon Smith
    Jonathan Shamash
    Oncology and Therapy, 2020, 8 : 209 - 230
  • [50] Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
    Ng, Kenrick
    Smith, Shievon
    Shamash, Jonathan
    ONCOLOGY AND THERAPY, 2020, 8 (02) : 209 - 230
12345